| Literature DB >> 18818905 |
Elise E DeVito1, Andrew D Blackwell, Luke Clark, Lindsey Kent, Anna Maria Dezsery, Danielle C Turner, Michael R F Aitken, Barbara J Sahakian.
Abstract
RATIONALE: Impulsivity is a cardinal feature of attention deficit hyperactivity disorder (ADHD), which is thought to underlie many of the cognitive and behavioural symptoms associated with the disorder. Impairments on some measures of impulsivity have been shown to be responsive to pharmacotherapy. However, impulsivity is a multi-factorial construct and the degree to which different forms of impulsivity contribute to impairments in ADHD or respond to pharmacological treatments remains unclear.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18818905 PMCID: PMC2704617 DOI: 10.1007/s00213-008-1337-y
Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN: 0033-3158 Impact factor: 4.530
IST key measures
| IST measure | Group/session | Fixed win, mean (SEM) | Decreasing win, mean (SEM) |
|---|---|---|---|
| Boxes opened | HC | 16.83 (1.00) | 7.66 (0.65) |
| ADHD-placebo | 17.81 (1.45) | 6.92 (1.13) | |
| ADHD-MPH | 16.26 (1.53) | 5.83 (1.03) | |
| Quality of information | HC | 0.86 (0.02) | 0.70 (0.01) |
| ADHD-placebo | 0.87 (0.03) | 0.67 (0.02) | |
| ADHD-MPH | 0.83 (0.12) | 0.66 (0.09) | |
| Choice latencya | HC | 3.34 (0.80) | 1.78 (0.15) |
| ADHD-placebo | 4.72 (0.92) | 2.23 (0.24) | |
| ADHD-MPH | 3.96 (0.91) | 2.38 (0.38) | |
| Poor decisions | HC | 0.38 (0.15) | 0.62 (0.03) |
| ADHD-placebo | 1.33 (0.26) | 1.94 (0.37) | |
| ADHD-MPH | 1.00 (0.23) | 1.72 (0.48) |
HC healthy control group, ADHD-placebo attention deficit hyperactivity group on placebo, ADHD-MPH attention deficit hyperactivity group on methylphenidate
aLatency measures are reported in seconds
Fig. 1Group and drug effects on IST poor decisions and SST SSRT
IST poor decision trials versus sensible decision trials
| IST measure | Group/session | Trial decision | Fixed win, mean (SEM) | Decreasing win, mean (SEM) |
|---|---|---|---|---|
| Quality of information | ADHD-placebo | Poor | 0.79 (0.05) | 0.64 (0.03) |
| Sensible | 0.89 (0.02) | 0.67 (0.02) | ||
| ADHD-MPH | Poor | 0.90 (0.05) | 0.64 (0.04) | |
| Sensible | 0.85 (0.02) | 0.68 (0.02) | ||
| Choice latencya | ADHD-placebo | Poor | 5.04 (1.67) | 2.37 (0.35) |
| Sensible | 4.53 (0.91) | 2.25 (0.27) | ||
| ADHD-MPH | Poor | 2.32 (0.54) | 2.00 (0.31) | |
| Sensible | 4.50 (0.90) | 2.93 (0.53) |
ADHD-placebo attention deficit hyperactivity group on placebo, ADHD-MPH attention deficit hyperactivity group on methylphenidate
aLatency measures are reported in seconds
SST key measures
| SST measure | Group/session | Mean (SEM) |
|---|---|---|
| SSRT | HC | 263.93 (20.0) |
| ADHD-placebo | 376.84 (22.01) | |
| ADHD-MPH | 242.80 (19.30) | |
| Median go RTa | HC | 442.76 (22.76) |
| ADHD-placebo | 548.42 (30.86) | |
| ADHD-MPH | 520.21 (26.42) | |
| SD go RTa | HC | 175.46 (73.61) |
| ADHD-placebo | 530.18 (77.39) | |
| ADHD-MPH | 225.36 (28.10) |
HC healthy control group, ADHD-placebo attention deficit hyperactivity group on placebo, ADHD-MPH attention deficit hyperactivity group on methylphenidate, SSRT stop signal reaction time
aReaction time (RT) measures are reported in milliseconds
Fig. 2More uncertainty tolerated prior to decision-making associated with self-rated impulsivity in ADHD-placebo
Fig. 3Self-rated empathy not impulsivity associated with behaviour ratings